Promiliad Biopharma is an innovative drug discovery company that creates novel natural product-like small molecules in combinatorial arrays. Promiliad has developed a proprietary and unique approach to the drug discovery process, a technology called ReBACS (Recombinant Biotechnology Assisted Combinatorial Synthesis). The natural product-based feedstock generated by ReBACS offers a complex and rich structural diversity, simplifies the synthetic challenge in drug discovery and increases the probability of generating new lead compounds. We facilitate the identification of lead compounds, the preparation of focused libraries and the efficient scale up of lead production.

Based on our natural product-like compound arrays, Promiliad Biopharma has established internal drug discovery programs that are focused on the development of new antibacterial and antifungal agents.